PIRO, SOFIA
 Distribuzione geografica
Continente #
NA - Nord America 140
AS - Asia 95
EU - Europa 53
SA - Sud America 19
AF - Africa 5
Totale 312
Nazione #
US - Stati Uniti d'America 135
SG - Singapore 33
HK - Hong Kong 26
SE - Svezia 21
CN - Cina 17
BR - Brasile 16
BG - Bulgaria 11
VN - Vietnam 11
IT - Italia 7
FR - Francia 4
SN - Senegal 4
AR - Argentina 3
AT - Austria 3
TR - Turchia 3
DE - Germania 2
RU - Federazione Russa 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BE - Belgio 1
CA - Canada 1
DO - Repubblica Dominicana 1
FI - Finlandia 1
HN - Honduras 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
KE - Kenya 1
MX - Messico 1
PA - Panama 1
UA - Ucraina 1
Totale 312
Città #
Ashburn 29
Hong Kong 26
Singapore 19
Chandler 15
Santa Clara 15
Sofia 11
Dallas 9
Fairfield 8
Beijing 6
New York 6
Shanghai 6
Boardman 5
Dakar 4
Houston 4
Norwalk 4
Rome 4
San Diego 4
Lawrence 3
Marseille 3
Princeton 3
Cambridge 2
Hanoi 2
Ho Chi Minh City 2
Istanbul 2
Los Angeles 2
Redondo Beach 2
São Paulo 2
Vienna 2
Baku 1
Bologna 1
Brussels 1
Buenos Aires 1
Buffalo 1
Cabo Frio 1
Cachoeirinha 1
Calgary 1
Capivari 1
Carmópolis 1
Chicago 1
Congonhas 1
Corrientes 1
Curitiba 1
Da Nang 1
Dong Ket 1
Erechim 1
Falkenstein 1
Fossacesia 1
Frankfurt am Main 1
Haikou 1
Haiphong 1
Hangzhou 1
Helsinki 1
Kocaeli 1
Londrina 1
Lấp Vò 1
Madiun 1
Mariupol 1
Medford 1
Miami 1
Nairobi 1
Newark 1
Nova Redenção 1
Ogden 1
Osasco 1
Pachuca 1
Panama City 1
Quảng Ngãi 1
Quận Ninh Kiều 1
Quận Năm 1
Rio de Janeiro 1
Saint Cloud 1
San Pedro Sula 1
Santo Domingo 1
Seattle 1
Serra 1
Stockholm 1
Suzano 1
Uberlândia 1
Villa Ballester 1
Vitória da Conquista 1
Washington 1
Wilmington 1
Totale 254
Nome #
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress (Scientific Reports, (2017), 7, 1, (11863), 10.1038/s41598-017-11070-x) 127
Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study 108
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study 84
Totale 319
Categoria #
all - tutte 1.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 0 0 0 12 0 3 4 0 1
2021/202241 0 5 3 1 11 4 3 2 0 4 3 5
2022/202349 7 8 5 1 5 6 0 4 10 0 0 3
2023/202420 1 1 4 0 2 7 0 1 0 0 1 3
2024/202597 0 3 0 5 12 10 17 7 11 12 8 12
2025/202692 14 22 20 14 18 4 0 0 0 0 0 0
Totale 319